F.J. Gildehaus

1.2k total citations
20 papers, 887 citations indexed

About

F.J. Gildehaus is a scholar working on Radiology, Nuclear Medicine and Imaging, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, F.J. Gildehaus has authored 20 papers receiving a total of 887 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Radiology, Nuclear Medicine and Imaging, 7 papers in Genetics and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in F.J. Gildehaus's work include Radiopharmaceutical Chemistry and Applications (11 papers), Glioma Diagnosis and Treatment (7 papers) and Medical Imaging Techniques and Applications (6 papers). F.J. Gildehaus is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (11 papers), Glioma Diagnosis and Treatment (7 papers) and Medical Imaging Techniques and Applications (6 papers). F.J. Gildehaus collaborates with scholars based in Germany, United States and Sweden. F.J. Gildehaus's co-authors include Klaus Tatsch, Gabriele Pöpperl, Friedrich W. Kreth, Walter Koch, Jörg C. Tonn, Jochen Herms, Hans A. Kretzschmar, Jan H. Mehrkens, Klaus Seelos and Guido Böning and has published in prestigious journals such as NeuroImage, Journal of neurosurgery and Oncotarget.

In The Last Decade

F.J. Gildehaus

18 papers receiving 880 citations

Peers

Countries citing papers authored by F.J. Gildehaus

Since Specialization

Citations

This map shows the geographic impact of F.J. Gildehaus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F.J. Gildehaus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F.J. Gildehaus more than expected).

Fields of papers citing papers by F.J. Gildehaus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F.J. Gildehaus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F.J. Gildehaus. The network helps show where F.J. Gildehaus may publish in the future.

Co-authorship network of co-authors of F.J. Gildehaus

This figure shows the co-authorship network connecting the top 25 collaborators of F.J. Gildehaus. A scholar is included among the top collaborators of F.J. Gildehaus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F.J. Gildehaus. F.J. Gildehaus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fibrillar amyloidosis and synaptic vesicle protein expression progress jointly in the cortex of a mouse model with β-amyloid pathology 2025 ·NeuroImage ·Lea H. Kunze, Giovanna Palumbo, Johannes Gnörich, Karin Wind, (unknown), Simon Lindner, F.J. Gildehaus, Slava Ziegler, Matthias Brendel	1
2	Comparison of the Hematotoxicity of PRRT with Lutathera® and Locally Manufactured 177Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals 2025 ·Cancers ·Markus Hofmann, (unknown), Marcus Unterrainer, (unknown), Adrien Holzgreve, Johannes Toms, F.J. Gildehaus, Christoph J. Auernhammer, Christine Spitzweg, Mathias J. Zacherl, Harun Ilhan, Johannes Rübenthaler, Leonie Beyer, Lena M. Unterrainer	1
3	Refining the clinical utility of [177Lu]Lu/[225Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancer 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), (unknown), (unknown), F.J. Gildehaus, Nina-Sophie Schmidt-Hegemann, Vera Wenter, (unknown), (unknown), Jozefina Casuscelli, Christian G. Stief, Mathias J. Zacherl, Rudolf A. Werner	0
4	Image-based dosimetry for 225Ac-PSMA-I&T therapy using quantitative SPECT 2020 ·European Journal of Nuclear Medicine and Molecular Imaging ·Astrid Gosewisch, (unknown), F.J. Gildehaus, (unknown), Lena Kaiser, Julia Brosch-Lenz, P. Bartenstein, Andrei Todica, Harun Ilhan, Guido Böning	30
5	Evaluation of 177Lu[Lu]-CHX-A″-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII 2018 ·Nuclear Medicine and Biology ·(unknown), (unknown), Astrid Gosewisch, (unknown), Guido Böning, Simon Lindner, Nathalie L. Albert, Peter Bartenstein, H.-J. Reulen, Reinhard Zeidler, F.J. Gildehaus	22
6	Produktion und Qualitätskontrolle von Radiopharmaka mittels zugelassener Kits 2018 ·Der Nuklearmediziner ·F.J. Gildehaus	0
7	Aufbau eines GMP-Radionuklidlabors 2017 ·Der Nuklearmediziner ·F.J. Gildehaus	1
8	Monitoring of Tumor Growth with [18F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches 2016 ·Frontiers in Neuroscience ·Adrien Holzgreve, Matthias Brendel, Song Gu, Janette Carlsen, Erik Mille, Guido Böning, (unknown), Marcus Unterrainer, F.J. Gildehaus, Axel Rominger, Peter Bartenstein, Roland E. Kälin, Rainer Glaß, Nathalie L. Albert	9
9	Preliminary experience with dosimetry, response and patient reported outcome after 177Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer 2016 ·Oncotarget ·Wolfgang P. Fendler, (unknown), Harun Ilhan, Andreas Delker, Guido Böning, F.J. Gildehaus, Christian G. Stief, Peter Bartenstein, Christian Gratzke, Sebastian Lehner, Axel Rominger	167
10	Long-term outcome of patients with WHO Grade III and IV gliomas treated by fractionated intracavitary radioimmunotherapy 2015 ·Journal of neurosurgery ·H.-J. Reulen, Gabriele Poepperl, Claudia Goetz, F.J. Gildehaus, Michael Schmidt, Klaus Tatsch, Torsten Pietsch, Theo F. J. Kraus, Walter Rachinger	21
11	Single-Dose GSTP1 Prevents Infarction-Induced Heart Failure 2014 ·Journal of Cardiac Failure ·Olena Andrukhova, Mohamed Salama, Martin Krššák, Dominik Wiedemann, (unknown), Marcus Hacker, F.J. Gildehaus, Oleh Andrukhov, Siroos Mirzaei, Alfred Kocher, Andreas Zuckermann, Seyedhossein Aharinejad	7
12	FET PET for the evaluation of untreated gliomas: correlation of FET uptake and uptake kinetics with tumour grading 2007 ·European Journal of Nuclear Medicine and Molecular Imaging ·Gabriele Pöpperl, Friedrich W. Kreth, Jan H. Mehrkens, Jochen Herms, Klaus Seelos, Walter Koch, F.J. Gildehaus, Hans A. Kretzschmar, Jörg C. Tonn, Klaus Tatsch	231
13	Serial O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of intracavitary radioimmunotherapy in patients with malignant glioma 2006 ·European Journal of Nuclear Medicine and Molecular Imaging ·Gabriele Pöpperl, (unknown), Walter Rachinger, Oliver Schnell, F.J. Gildehaus, J. C. Tonn, Klaus Tatsch	60
14	Long-term assessment of striatal dopamine transporters in parkinsonian patients with intrastriatal embryonic mesencephalic grafts 2006 ·European Journal of Nuclear Medicine and Molecular Imaging ·Oliver Pogarell, Walter Koch, F.J. Gildehaus, Andreas Kupsch, Olle Lindvall, Wolfgang H. Oertel, Klaus Tatsch	19
15	Analysis of 18F-FET PET for grading of recurrent gliomas: is evaluation of uptake kinetics superior to standard methods? 2006 ·PubMed ·Gabriele Pöpperl, Friedrich W. Kreth, Jochen Herms, Walter Koch, Jan H. Mehrkens, F.J. Gildehaus, Hans A. Kretzschmar, Jörg C. Tonn, Klaus Tatsch	157
16	O-(2-[18F]fluoroethyl)-l-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma 2005 ·European Journal of Nuclear Medicine and Molecular Imaging ·Gabriele Pöpperl, Roland Goldbrunner, F.J. Gildehaus, Friedrich W. Kreth, (unknown), Markus Holtmannspötter, J. C. Tonn, Klaus Tatsch	81
17	Lymph kinetics with technetium-99m labeled radiopharmaceuticals 2005 ·Nuklearmedizin - NuclearMedicine ·F.J. Gildehaus, (unknown), (unknown), (unknown), (unknown)	16
18	Locoregional radioimmunotherapy in selected patients with malignant glioma: experiences, side effects and survival times 2003 ·Journal of Neuro-Oncology ·Claudia Goetz, Paola Riva, (unknown), F.J. Gildehaus, (unknown), Klaus Tatsch, H.-J. Reulen	40
19	Intralesional radioimmunotherapy in the treatment of malignant glioma: clinical and experimental findings 2003 ·Acta neurochirurgica. Supplementum ·Claudia Goetz, Walter Rachinger, (unknown), Markus Decker, F.J. Gildehaus, Susanne Stocker, Gundram Jung, Klaus Tatsch, J. C. Tonn, H.-J. Reulen	9
20	Initial experience with locoregional radioimmunotherapy using 131I-labelled monoclonal antibodies against tenascin (BC-4) for treatment of glioma (WHO III and IV) 2002 ·Nuklearmedizin - NuclearMedicine ·(unknown), F.J. Gildehaus, Tarek Yousry, H.-J. Reulen, K. Hahn, Klaus Tatsch, Gabriele Pöpperl	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact